Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.
P2860
Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@en
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@nl
type
label
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@en
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@nl
prefLabel
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@en
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@nl
P2093
P2860
P1433
P1476
Epitope-positive truncating ML ...... ic testing for Lynch syndrome.
@en
P2093
Alison J Whelan
Amy P Schmidt
Israel Zighelboim
Leigha Senter
Mark Clendenning
Matthew A Powell
Paul J Goodfellow
Sheri A Babb
Stephen N Thibodeau
P2860
P2888
P304
P356
10.1007/S10689-009-9276-2
P577
2009-08-12T00:00:00Z